MedGenome says cancer vaccine approach can help in Lynch Syndrome treatment
MedGenome, an Indian genomics research and diagnostics startup, in a recent study has found out that using a cancer vaccine
Continue readingCoverage of Global Pharma Industry News
MedGenome, an Indian genomics research and diagnostics startup, in a recent study has found out that using a cancer vaccine
Continue readingGerman pharma company Boehringer Ingelheim has exercised its option to acquire 100% of Austria-based oncolytic virus company ViraTherapeutics for €210
Continue readingLumoxiti FDA approval : AstraZeneca has bagged the US Food and Drug Administration (FDA) approval for its CD22-directed cytotoxin Lumoxiti
Continue readingUS oncology company Oncternal Therapeutics said that the first patient enrolled in a phase 1b trial of its investigational breast
Continue readingGerman pharma company Boehringer Ingelheim said that Cyltezo, a biosimilar to AbbVie psoriasis drug Humira, achieved clinical equivalence to the
Continue readingMerck has bagged the European Commission approval for the combination of its anti-PD-1 cancer immunotherapy Keytruda (pembrolizumab) with Lilly’s chemotherapy
Continue readingIrish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS
Continue readingA new US biotech company called Twentyeight-Seven Therapeutics (28-7) has been launched in Cambridge, which will focus on modulating non-coding
Continue readingUK biopharma company AstraZeneca and Amgen have secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for
Continue readingPvP Biologics, a US pharma company, has initiated two phase 1 clinical trials for Kuma062 to evaluate the recombinant enzyme
Continue reading